1832 Asset Management L.P. Abb Vie Inc. Transaction History

1832 Asset Management L.P.

$55.8 Billion
Q3 2024

A detailed history of 1832 Asset Management L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, 1832 Asset Management L.P. holds 136,078 shares of ABBV stock, worth $24.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

136,078

Previous 122,876 10.74%

Holding current value

$24.5 Million

Previous $21.1 Million 27.51%

% of portfolio

0.05%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $2.16 Million - $2.63 Million	13,202 Added 10.74%	136,078 $26.9 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $106 Million - $124 Million	-687,984 Reduced 84.85%	122,876 $21.1 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $120 Million - $137 Million	752,043 Added 1278.62%	810,860 $148 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $118,886 - $133,894	864 Added 1.49%	58,817 $9.11 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $7.74 Million - $8.96 Million	57,953 New	57,953 $8.64 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $3.2 Million - $3.98 Million	-24,163 Reduced 37.58%	40,126 $5.41 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $5.81 Million - $6.69 Million	40,194 Added 166.81%	64,289 $10.2 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $2.23 Million - $2.68 Million	-16,151 Reduced 40.13%	24,095 $3.9 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $442,087 - $507,045	-3,294 Reduced 7.57%	40,246 $5.4 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $23.8 Million - $30.3 Million	-173,074 Reduced 79.9%	43,540 $6.67 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $26.1 Million - $32.4 Million	197,993 Added 1063.28%	216,614 $34.6 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $1.2 Million - $1.52 Million	-11,205 Reduced 37.57%	18,621 $2.55 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.32 Million - $1.5 Million	12,424 Added 71.39%	29,826 $3.28 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1.02 Million - $1.14 Million	9,734 Added 126.94%	17,402 $1.96 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $44.6 Million - $49.1 Million	-435,596 Reduced 98.27%	7,668 $828,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $29.5 Million - $39.8 Million	365,982 Added 473.57%	443,264 $46.8 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $17.6 Million - $20.7 Million	-205,050 Reduced 72.63%	77,282 $6.76 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $14.5 Million - $19.4 Million	197,400 Added 232.42%	282,332 $27.5 Million
Q1 2020 May 26, 2020	BUY	$64.5 - $97.79 $4.99 Million - $7.56 Million	77,300 Added 1012.84%	84,932 $6.44 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $2.85 Million - $4.32 Million	-44,183 Reduced 85.27%	7,632 $585,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $6,419 - $8,032	-89 Reduced 0.17%	51,815 $4.61 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $313,514 - $376,934	4,978 Added 10.61%	51,904 $3.88 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $3.07 Million - $3.92 Million	46,726 Added 23363.0%	46,926 $3.29 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $3,934 - $4,630	-51 Reduced 20.32%	200 $15,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $9,186 - $11,329	-118 Reduced 31.98%	251 $23,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $16,092 - $17,890	-181 Reduced 32.91%	369 $35,000
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $914,319 - $1.08 Million	-10,184 Reduced 94.88%	550 $52,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $182,915 - $244,941	1,988 Added 22.73%	10,734 $986,000
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $360,210 - $395,000	-4,022 Reduced 31.5%	8,746 $817,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $891,844 - $1.14 Million	12,768	12,768 $1.1 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.

Account

1832 Asset Management L.P. Abb Vie Inc. Transaction History